If (ever) a lab received a funding boost to increase their coronavirus testing capacity, it would be going straight to the Virology/PCR lab...not the bacteriology lab where APAS has it's place.
This myth of APAS addressing viral pandemics has come up on this forum a few times now. Coronavirus is (Lo and behold) a virus. APAS has its application in testing for BACTERIA. This stock will not benefit from the coronavirus scare-mongering.
Dr Hansen, page-31
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $23.30M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $8.549K | 565.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 250000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 188838 | 1 |
View Market Depth
| Last trade - 11.33am 09/07/2024 (20 minute delay) ? |
| LBT (ASX) Chart |